Understanding the mechanisms underlying Tau-mediated glial dysfunction may provide insights into the pathogenesis of Tauopathies and identify potential therapeutic targets for these devastating neurodegenerative diseases. The gene discussed is MAPT; the disease is neurodegenerative disease.